证券代码：002566 证券简称：益盛药业 公告编号：2026-006 | 受托方 | 名称 | 方正证 | 券股份 | 有限公 | 司 | 上海国 | 泰君安 | | 证券资 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 产品类型 | | 固定收益 | 类集合资 | 产管理计 | 划 | 【混合类】 | 单一资产 | | 管理计划 | | | | | 产品名称 | | 方正证券 稳泰多资 | 产组合策 | 略 1 号单 | 一资产管 | 国泰君安 | 私客尊享 | | FOF5387 | 理计划 | | | | 收益 | 类型 | 非保 | 本浮 | 动收 | 益型 | 非保 | 本浮 | | 动收 | | | | | 起息日 | | | 2025 | 月 28 | | 2025 | | 月 29 | | | | | | | | | | 日 | | 年4 | | 日 | | | 年4 | | | 金额 实际收 是否赎 | 到期日 （万 益（万 回 元） 元） | | 2026 ...

证券代码：002566 证券简称：益盛药业 公告编号：2026-005 吉林省集安益盛药业股份有限公司 关于使用闲置自有资金购买理财产品到期赎回的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 吉林省集安益盛药业股份有限公司（以下简称"公司"）于 2025 年 3 月 10 日召开第八届董事会第十七次会议、第八届监事会第十七次会议，审议通过了《关 于使用闲置自有资金购买理财产品的议案》，为提高公司资金使用效率，合理利 用闲置自有资金，在保证日常经营资金需求和资金安全的前提下，公司及子公司 使用不超过 10,000 万元人民币的闲置自有资金购买理财产品。在上述额度内资 金可以滚动使用，使用期限不超过 12 个月。内容详见公司于 2025 年 3 月 11 日 在指定信息披露媒体及巨潮资讯网（www.cninfo.com.cn）披露的《关于使用闲 置自有资金购买理财产品的公告》（公告编号 2025-010）。 二、本公告前十二个月内使用闲置自有资金购买理财产品的管理情况 | 受托方 | 产品类型 | 产品名称 | 收益 | 起息日 | | 到期日 | | 金 ...

Group 1 - The core point of the article is that Yisheng Pharmaceutical (002566) has reported its total number of shareholders as of February 10, 2026, which stands at 22,043 households [1]

Group 1: Industry Overview - The Chinese medicine industry is receiving favorable policies, with the Ministry of Industry and Information Technology and seven other departments issuing the "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" on February 6, 2026, aiming to promote the approval of innovative traditional Chinese medicine drugs and cultivate leading enterprises by 2030 [1] - This policy is expected to provide long-term support for companies like Yisheng Pharmaceutical (002566) [1] Group 2: Company Actions - Yisheng Pharmaceutical announced on February 4, 2026, that it plans to use no more than 50 million yuan of idle funds to purchase financial products, aiming to improve capital efficiency, and this plan has been approved by the board of directors [1] Group 3: Stock Performance - Over the past seven trading days (February 5 to 11, 2026), Yisheng Pharmaceutical's stock price increased by 1.81%, reaching a high of 8.55 yuan, and closed at 8.45 yuan on February 11, with a slight decline of 0.12% on that day [2] - On February 6, there was a net inflow of 1.7795 million yuan in main funds, but a net outflow was observed on February 11 [2] - The current stock price is above the 20-day moving average of 8.194 yuan, and the MACD indicator maintains a bullish signal [2] Group 4: Institutional Insights - Market attention towards Yisheng Pharmaceutical is generally moderate, with institutional ratings primarily neutral [3] - The stock's price-to-earnings ratio (TTM) is 69.31 times, which is higher than the industry average, indicating relatively weak competitiveness and growth potential within the industry, with the overall valuation being in a reasonable range [3] - The fund holding ratio is low at only 0.63%, reflecting limited institutional participation [3]

证券代码：002566 证券简称：益盛药业 公告编号：2026-004 吉林省集安益盛药业股份有限公司 关于使用闲置自有资金购买理财产品的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 吉林省集安益盛药业股份有限公司（以下简称"公司"）于 2026 年 2 月 4 日召开第九届董事会第五次会议，审议通过了《关于使用闲置自有资金购买理财 产品的议案》，为提高公司资金使用效率，合理利用闲置自有资金，在保证日常 经营资金需求和资金安全的前提下，公司使用不超过 5,000 万元人民币的闲置自 有资金购买理财产品。内容详见公司于 2026 年 2 月 5 日在指定信息披露媒体及 巨潮资讯网（www.cninfo.com.cn）披露的《关于使用闲置自有资金购买理财产 品的公告》（公告编号 2026-003）。 根据上述决议，公司使用 5,000 万元人民币闲置自有资金购买了上海国泰海 通证券资产管理有限公司理财产品，现将具体情况公告如下： 一、本次使用闲置自有资金购买理财产品的基本情况 公司与上海国泰海通证券资产管理有限公司签署了《国泰海通私客尊享 FOF850 ...

Core Viewpoint - The company, Jilin Province Jichang Yisheng Pharmaceutical Co., Ltd., has approved the use of idle self-owned funds to purchase financial products to enhance fund utilization efficiency and increase returns while ensuring operational needs and fund safety [4][10]. Group 1: Meeting Details - The ninth board meeting was held on February 4, 2026, with all nine directors present, and the meeting was deemed legal and effective [1]. - The board unanimously approved the proposal to use idle self-owned funds for purchasing financial products with a vote of 9 in favor, 0 against, and 0 abstentions [1]. Group 2: Investment Proposal - The company plans to use no more than 50 million RMB of idle self-owned funds for purchasing financial products, with a maximum investment period of 12 months [4][5]. - The investment aims to improve fund utilization efficiency and increase company returns without affecting normal business operations [4][10]. Group 3: Investment Guidelines - The company will invest in financial products issued by banks, securities firms, and asset management companies, focusing on high safety and good liquidity [6]. - The financial director is authorized to sign relevant contracts within the approved limit, and the finance department will oversee the implementation [6][7]. Group 4: Impact on Operations - The funds used for purchasing financial products will be limited to idle self-owned funds, ensuring that daily operational needs and fund safety are prioritized [10]. - This investment strategy is expected to enhance fund efficiency and yield, contributing positively to the company's overall performance and shareholder interests [10].

第九届董事会第五次会议决议公告 证券代码：002566 证券简称：益盛药业 公告编号：2026-002 吉林省集安益盛药业股份有限公司 二、备查文件 公司第九届董事会第五次会议决议。 特此公告。 吉林省集安益盛药业股份有限公司董事会 二〇二六年二月四日 1 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 吉林省集安益盛药业股份有限公司（以下称"公司"）第九届董事会第五次 会议通知以当面送达、电话、邮件的方式于2026年1月28日向各董事发出，会议 于2026年2月4日以现场会议的方式在公司四楼会议室召开。会议应参加审议董事 9人，实际参加审议董事9人。本次会议的召开符合《公司法》及《公司章程》的 规定，合法有效。会议由董事长张益胜先生主持，审议并通过了如下议案： 一、会议以9票同意、0票反对、0票弃权的表决结果，审议通过了《关于使 用闲置自有资金购买理财产品的议案》。 《关于使用闲置自有资金购买理财产品的公告》详见《中国证券报》、《上 海证券报》、《证券时报》及巨潮资讯网（www.cninfo.com.cn）。 ...

Group 1 - The company Yisheng Pharmaceutical held its ninth fifth board meeting on February 4, 2026, to discuss the proposal for using idle self-owned funds to purchase financial products [1] - The meeting took place in the company's fourth-floor conference room [1] Group 2 - The article discusses Kevin Walsh's new policy concept, which involves a dual approach of monetary easing and tightening, aiming to control inflation with the help of AI [1] - It highlights Walsh's stance against being a major buyer of U.S. Treasury bonds [1]

证券代码：002566 证券简称：益盛药业 公告编号：2026-003 吉林省集安益盛药业股份有限公司 关于使用闲置自有资金购买理财产品的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 吉林省集安益盛药业股份有限公司（以下简称"公司"）于 2026 年 2 月 4 日召开第九届董事会第五次会议，审议通过了《关于使用闲置自有资金购买理财 产品的议案》，为提高公司资金使用效率，合理利用闲置自有资金，在保证日常 经营资金需求和资金安全的前提下，公司拟使用不超过 5,000 万元人民币的闲置 自有资金购买理财产品。在上述额度内资金可以滚动使用，使用期限不超过 12 个月。具体情况如下： 5、资金来源：公司闲置自有资金。 6、决策程序：本事项需经董事会审议通过。 二、投资风险及风险控制措施 一、本次关于使用闲置自有资金购买理财产品的基本情况 1、投资目的：为提高资金使用效率，合理利用闲置资金，在不影响公司正 常经营业务和有效控制风险的前提下，增加公司收益。 2、投资额度及投资期限：公司拟使用不超过 5,000 万元人民币的闲置自有 资金购买理财产品。投资期限为自董 ...

Group 1 - The core point of the article is that Yisheng Pharmaceutical (002566) reported a total of 21,673 shareholders as of January 30, 2026 [1]